caroline rousseau - UMR 6299, CNRS | 人才画像

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 160 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Potential of TSPO Radioligands: Bridging Brain Tumor Diagnostics to the Peripheries

F. Avry,C. Rousseau, F. Kraeber-Boere, M. Bourgeois,Nicolas Arlicot

BIOCHIMIE (2024): 114-119

引用0浏览0WOS引用

Does urinary excretion rate change over the courses of 177Lu-PSMA therapies

L. Ferrer, M. Chabiron,C. Rousseau,N. Varmenot

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGINGno. SUPPL 1 (2023): S365-S365

引用0浏览0引用

Predictive value of [18F]F-Choline and PSMA-based quantitative parameters for response to [177Lu] Lu-PSMA-617 therapy in mCRPC: The added value of dynamic FDG acquisition using Patlak method

S. Miet,B. Maucherat,P. Baumgartner,E. Picot-Dilly, P. Lalire,A. Morel-Thierry,D. Rusu,M. Le Thiec, V. Nicolas, F. Rolland,C. Rousseau,L. Ferrer

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGINGno. SUPPL 1 (2023): S90-S90

引用0浏览0引用

Evaluation of [64Cu]Cu-ATSM PET-CT as a response predictor to neoadjuvant therapy in locally advanced rectal cancer: preliminary results

M. Le Thiec,L. Ferrer,M. Colombie,M. Lacombe,A. Devillers,P. Salaun,S. Hiret, J. Raimbourg, L. Doucet,E. Rio, S. Lesourd,P. Tremolieres, M. Heymann,N. Varmenot,A. Vidal,F. Haddad,N. Allam,M. Cherel,F. Kraeber-Bodere,L. Campion, M. Bourgeois,C. Rousseau

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGINGno. SUPPL 1 (2023): S70-S70

引用0浏览0引用

Diagnostic Différentiel Entre Radionécrose Cérébrale Et Rechute Locale Après Radiothérapie Intracrânienne : Intérêt De La TEP-IRM FDG

A. Cailleteau,L. Ferrer, R. Movassaghi,D. Geffroy,C. Rousseau,M. Doré,V. Fleury

Médecine Nucléaireno. 2 (2023): 48-48

引用0浏览0引用

Étude Prospective TEP/TDM Au 68GA-PSMA Chez Des Patients En Récidive Occulte Du Cancer De La Prostate (rebioloc) : Impact Sur La Décision Thérapeutique Et Bénéfice À Long Terme

C. Rousseau,L. Ferrer,M. Le thiec,M. Frindel,D. Rusu,B. Maucherat,A. Rauscher,S. Supiot,T. Rousseau,A. Morel,L. Campion,F. Kraeber-bodéré

Progrès en urologie Formation médicale continue/Progrès en urologie FMCno. 3 (2023): S82-S82

引用0浏览0引用

Methodological development of the intravesical injection of 89Zr-girentixumab for the trial PERTINENCE: Technical feasibility, radiation protection, dosimetry

A. Grassal,C. Rousseau, C. Pitel,F. Delaunay,N. Varmenot,M. Frindel,L. Ferrer,J. Chatal,A. Rauscher,P. Baumgartner

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING（2022）

引用0浏览0引用

Preliminary results of a clinical feasibility study with intravesically instilled Zr-89-labeled Girentuximab in patients with non-muscle-invasive bladder cancer for future alpha-immunotherapy

C. Rousseau, M. Geffroy,T. Rousseau,M. F. Heymann, M. Taupin,J. Lacoste, J. F. Chatal,L. Ferrer,P. Baumgartner,N. Varmenot

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING（2022）

引用0浏览0引用

Preliminary resultats of correlatation between triple-negative breast cancer cluster, SUV parameters, TLG and textural features assessed with 18F-FDG PET/CT in a prospective study

V. Fleury,L. Ferrer,O. Kerdraon,B. Maucherat,M. Le Thiec,D. Rusu,A. Morel-Thierry,E. Picot-Dilly,M. Lacombe,C. Rousseau,F. Kraeber-Bodere

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING（2022）

引用0浏览0引用

New radionuclides for theranostic applications: a methodology for evaluating the dosimetry impact in clinics

N. Varmenot, T. Pham,A. Vergara-Gil, M. Nzatsi-Nzatsi,C. Rousseau,F. Haddad,L. Ferrer

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING（2022）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn